Research Engineer in DNA Repair and Translational Cancer Drug Development
- Deadline
- 11 Dec 2026 · 19 days left
- Location
- Solna, Sweden
- Type
- Research Assistant
- Compensation
- Individual monthly salary under KI collective agreements RALS and RALS-T
- Working language
- English
- Posted
- 21 Nov 2026
- Verified
- 21 Nov 2026
About this opportunity
The Helleday Laboratory at Karolinska Institutet in Solna, Sweden, is hiring a research engineer to support its work on DNA repair and translational drug development. The lab develops treatments for cancer, inflammation and fibrosis using small molecules and PROTAC technology. This is a permanent, full-time position in an international, collaborative group with modern infrastructure.
What is offered
- Permanent employment, full-time (100%), starting with a 6-month probationary period.
- Start date by agreement.
- Monthly salary set individually under KI's collective agreements (RALS and RALS-T).
- Collective agreement benefits, flexible working (partly remote where the work allows) and free access to on-site gym facilities.
- Hands-on work across several projects, including:
- planning, running and optimising lab experiments in molecular biology, cell biology and biochemistry;
- developing and running screening assays;
- generating, analysing and interpreting data;
- preclinical characterisation of the lab's compounds: biomarkers of treatment response, combination therapies, drug resistance mechanisms, and effects on the DNA damage response and cancer cell metabolism.
Who can apply
Requirements:
- A Master's degree in cell biology, molecular biology, biotechnology or a related field.
- At least three years of relevant hands-on lab experience after graduating.
- Documented experience setting up and working with disease models, preferably in oncology.
- Extensive cell culture experience with both bacterial and mammalian systems.
- Documented experience with cell viability and survival assays, clonogenic assays, qPCR, cloning, immunofluorescence and Western blot.
- Very good spoken and written English.
- Good skills in Microsoft Office, GraphPad Prism and ImageJ.
- Ability to work in an organised, structured way, meet deadlines and collaborate in multidisciplinary teams.
Merits:
- Experience with cancer cell lines and immunohistochemistry (IHC).
- Experience with target engagement assays such as CETSA and DARTS.
- Experience with drug dispensing systems, especially D300 and Echo.
- Experience with CellProfiler.
The lab says it will give great weight to personal qualities.
How to apply
- Apply online through KI's Varbi recruitment system using the link on the job page.
- Send only your CV. No cover letter is needed.
- Answer the questions in the application form about why you are applying.
- Deadline: 11 December 2026.
- Reference number: STÖD 2-4854/2026.
- Questions: Ann-Sofie Jemth, ann-sofie.jemth@ki.se.
Requirements
-
Open to all nationalities
-
Minimum degree: Master's
Research Engineer in DNA Repair and Translational Cancer Drug Development
11 Dec 2026 · 19 days left